Amgen Eyes Internet and Modest Sales Force to Launch Denosumab

The biotech company is betting it can reach the right doctors with the nowhere near as many reps as primary care powerhouses like Pfizer, GlaxoSmithKline and Merck have tapped to do that job in the past.